Bio-Plex 200 (Allergens)
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Points of contact
-
- HFP Acquisition Liaison hfpacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring a Bio-Plex 200 multiplex system to serve as the essential instrumentation platform for the xMAP Food Allergen Detection Assay (xMAP FADA). This advanced multiplex immunoassay system will simultaneously detect multiple food allergens, including gluten, in a single analytical test and is critical for replacing existing instrumentation that has approached the end of its operational reliability. The solicitation is estimated to be released on May 1, 2026, with an anticipated award date of September 1, 2026.
The estimated award value ranges from $25,000 to $250,000 under NAICS code 541990 (All Other Professional, Scientific, and Technical Services), with no set-aside provisions applied to this new requirement. This procurement will support ongoing method development and validation studies for food allergen detection. Inquiries regarding this opportunity should be directed to the Food and Drug Administration's Acquisition Liaison at hfpacquisitions@fda.hhs.gov.
Forecast text
This funding supports the procurement of a Bio-Plex multiplex system that serves as the essential instrumentation platform for the xMAP Food Allergen Detection Assay (xMAP FADA), an advanced multiplex immunoassay developed by FDA to simultaneously detect multiple food allergens, including gluten, in a single analytical test. This procurement is critical for replacing existing instrumentation that has approached the end of its operational reliability, ensuring continued support for ongoing method development and validation studies.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast